106
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Adjunctive continuous high-volume hemofiltration in acute severe pancreatitis patients: A retrospective study

, , , , , & show all
Pages 1363-1369 | Received 07 Jun 2009, Accepted 10 Aug 2009, Published online: 06 Nov 2009

References

  • Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349–53.
  • Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.
  • Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–91.
  • Mitchell RMS, Byrne MF, Baillie J. Pancreatitis. Lancet 2003;361:1447–55.
  • Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004;291:2865–8.
  • Ronco C, Bonello M, Bordoni V, Ricci Z, D'Intini V, Bellomo R. Extracorporea1 therapies in non-rena1 disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004;22:164– 74.
  • Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522–6.
  • Blinzler L, Hausser J, Bödeker H, Zaune U, Martin E, Gebhardt C. Conservative treatment of severe necrotizing pancreatitis using early continuous veno-venous hemo?ltration. Contrib Nephrol 1991;93:234–36.
  • Yekebas EF, Treede H, Knoefel WT, Bloechle C, Fink E, Izbicki JR. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 1999;229:514–22.
  • Yekebas EF, Strate T, Zolmajd S, Eisenberger CF, Erbersdobler A, Saalmüller A. Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 2002;62:1806–18.
  • Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P. Effects of different doses in continuous veno-venous hemo?ltration on outcomes in acute renal failure: a prospective, randomized trial Lancet 2000;355:26–30
  • Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 1999;25:814–21.
  • Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001;27:978–86.
  • Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004;50:102–9.
  • Ronco C. Recent evolution of renal replacement therapy in the critically ill patient. Crit Care 2006;10:123–8.
  • Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586–90.
  • Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup: Acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–12.
  • Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol 1997;92:377–86.
  • Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004;32:2524–36.
  • Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006;34:2099–104.
  • Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32:80–6.
  • Page B, Vieillard-Baron A, Chergui K, Peyrouset O, Rabiller A, Beauchet A. Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care 2005;9:R755–63.
  • Jacobs FM, Brivet FG. Early venovenous haemodiafiltration for sepsis-related multiple organ failure. Crit Care 2005;9:R755–63.
  • Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002;30:100–6
  • Li W, Yan X, Wang H, Zhang Z, Yu W, Ji D. Effects of continuous high-volume hemofiltration on experimental severe acute pancreatitis in pigs. Pancreas 2007;34:112–9.
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–29.
  • Liu TH, Kwong KL, Tamm EP, Gill BS, Brown SD, Mercer DW. Acute pancreatitis in intensive care unit patients: Value of clinical and radiologic prognosticators at predicting clinical course and outcome. Crit Care Med 2003;31:1026–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.